WHO okays emergency use of India’s COVAXIN vaccine

The World Health Organization’s Technical Advisory Group recommended on Wednesday that India’s coronavirus vaccine COVAXIN should be granted emergency use listing status.

The Indian first homegrown COVID-19 vaccine was developed by domestic company Bharat Biotech in collaboration with the country’s Council of Medical Research (ICMR) and the National Institute of Virology (NIV).

The two-dose vaccine has estimated to be 77.8% effective in preventing COVID-19 and 93.4% successful in preventing severe cases of coronavirus infection. The latest studies also determined the jab’s efficacy versus the Delta strain at 65.2%.

What's happening in Tunisia?
Subscribe to our Youtube channel for updates.

Top 48h

Copyright © 2019 Tunisie Numerique

To Top